| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
4e-09 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
5e-08 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
1e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-07 |
| mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.3 |
4e-07 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
4e-07 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
4e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
6e-07 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
7e-07 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-06 |